[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.247.249. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
May 1985

Neurotensin, Vasoactive Intestinal Peptide, and Roux-en-Y GastrojejunostomyTheir Role in the Dumping Syndrome

Author Affiliations

From the Department of Surgery, University of Texas Health Science Center, San Antonio (Drs Sirinek and McFee); and the Department of Medicine, Ohio State University College of Medicine, Columbus (Dr O'Dorisio and Mr Howe).

Arch Surg. 1985;120(5):605-609. doi:10.1001/archsurg.1985.01390290083014
Abstract

• This study evaluated the effect of gastric bypass on the glucose, insulin, vasoactive intestinal peptide (VIP), neurotensin, and motilin response to orally administered glucose in eight morbidly obese patients before and after operation. Preoperatively, all eight patients remained asymptomatic during an oral glucose tolerance test, which showed glucose intolerance and hyperinsulinism. Plasma VIP, neurotensin, and motilin remained below detectable levels for the entire test. At three months following gastric bypass (21% weight loss), all eight patients became acutely ill during a repeated oral glucose tolerance test and had the following symptoms: facial flushing (eight patients), palpitations (eight patients), nausea (seven patients), abdominal fullness (seven patients), pallor (four patients), diaphoresis (two patients), vomiting (two patients), and diarrhea (two patients). Significant release of neurotensin occurred in seven patients while three patients had release of VIP, further implicating these two peptides as part of the pathophysiologic spectrum of the "dumping syndrome."

(Arch Surg 1985;120:605-609)

×